Ir para o conteúdo
Advertisement

Surto de botulismo em bebês: a FDA ainda não sabe a causa – ou como evitá-la

No final, as três empresas envolvidas apontam o dedo umas para as outras.

schedule 22:36 visibility 9 visualizações
Surto de botulismo em bebês: a FDA ainda não sabe a causa – ou como evitá-la
Fonte: Ars Technica

The Food and Drug Administration this week posted what critics call an "underwhelming" epilogue to the devastating outbreak of botulism in babies, which was linked to spore-contaminated formula made by ByHeart. Despite clear tracking of the contamination, the regulator still doesn't know how the bacteria arrived in the formula—or how to prevent it from happening again.

"The FDA's investigation into the root cause is ongoing with a focus on ingredients," the agency reported.

In the void, three companies at the center of the investigation are left pointing fingers at each other, with none publicly taking responsibility for the contamination.

Read full article

Comments

newspaper

Publicado em

Ars Technica

open_in_new Ler artigo completo

Artigos relacionados